Pyrazinamide Susceptibility Testing in Mycobacterium tuberculosis: a Systematic Review with Meta-Analyses

Molecular Detection of Mutations Associated with First- and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing of Mycobacterium tuberculosis

(2011) Patricia J. Campbell et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand

(2010) Jirarut Jonmalung et al.   BMC MICROBIOLOGY

Treatment of tuberculosis: update 2010

(2010) W. W. Yew et al.   EUROPEAN RESPIRATORY JOURNAL

Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan

(2009) H. Ando et al.   CLINICAL MICROBIOLOGY AND INFECTION

Potential for Erroneous Results Indicating Resistance When Using the Bactec MGIT 960 System for Testing Susceptibility ofMycobacterium tuberculosisto Pyrazinamide

(2009) Pamela Chedore et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Sputum PCR-Single-Strand Conformational Polymorphism Test for Same-Day Detection of Pyrazinamide Resistance in Tuberculosis Patients

(2009) P. Sheen et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Characterisation of pncA mutations in clinical Mycobacterium tuberculosis isolates in New Zealand

(2009) Sushil Pandey et al.   PATHOLOGY

Pyrazinamide Resistance and pncA Gene Mutations in Mycobacterium tuberculosis

(2008) P. Jureen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pyrazinamide Resistance among South African Multidrug-Resistant Mycobacterium tuberculosis Isolates

(2008) M. Mphahlele et al.   JOURNAL OF CLINICAL MICROBIOLOGY